| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.3 | 0.0001 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0007 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.03 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |